Global T Cell Antigen Gp39 Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Buy Now

   Published Date : Nov-2017   |    Format : PDF   |    Pages : 103
In this report, the global T Cell Antigen Gp39 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of T Cell Antigen Gp39 in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global T Cell Antigen Gp39 market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Biogen, Inc.
    Bristol-Myers Squibb Company
    eTheRNA Immunotherapies NV
    ImmuNext, Inc.
    Juno Therapeutics Inc.
    MedImmune, LLC
    Targovax AS
    XL-protein GmbH
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ECI-006
    Hepatitis B vaccine
    INX-021
    ISF-35
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Graft Versus Host Disease
    Breast Cancer
    Bladder Cancer
    Panceratic Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global T Cell Antigen Gp39 Market Research Report 2017
1 T Cell Antigen Gp39 Market Overview
    1.1 Product Overview and Scope of T Cell Antigen Gp39
    1.2 T Cell Antigen Gp39 Segment by Type (Product Category)
        1.2.1 Global T Cell Antigen Gp39 Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global T Cell Antigen Gp39 Production Market Share by Type (Product Category) in 2016
        1.2.3 ECI-006
        1.2.4 Hepatitis B vaccine
        1.2.5 INX-021
        1.2.6 ISF-35
        1.2.7 Others
    1.3 Global T Cell Antigen Gp39 Segment by Application
        1.3.1 T Cell Antigen Gp39 Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Graft Versus Host Disease
        1.3.3 Breast Cancer
        1.3.4 Bladder Cancer
        1.3.5 Panceratic Cancer
        1.3.6 Others
    1.4 Global T Cell Antigen Gp39 Market by Region (2012-2022)
        1.4.1 Global T Cell Antigen Gp39 Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of T Cell Antigen Gp39 (2012-2022)
        1.5.1 Global T Cell Antigen Gp39 Revenue Status and Outlook (2012-2022)
        1.5.2 Global T Cell Antigen Gp39 Capacity, Production Status and Outlook (2012-2022)

2 Global T Cell Antigen Gp39 Market Competition by Manufacturers
    2.1 Global T Cell Antigen Gp39 Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global T Cell Antigen Gp39 Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global T Cell Antigen Gp39 Production and Share by Manufacturers (2012-2017)
    2.2 Global T Cell Antigen Gp39 Revenue and Share by Manufacturers (2012-2017)
    2.3 Global T Cell Antigen Gp39 Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers T Cell Antigen Gp39 Manufacturing Base Distribution, Sales Area and Product Type
    2.5 T Cell Antigen Gp39 Market Competitive Situation and Trends
        2.5.1 T Cell Antigen Gp39 Market Concentration Rate
        2.5.2 T Cell Antigen Gp39 Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global T Cell Antigen Gp39 Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global T Cell Antigen Gp39 Capacity and Market Share by Region (2012-2017)
    3.2 Global T Cell Antigen Gp39 Production and Market Share by Region (2012-2017)
    3.3 Global T Cell Antigen Gp39 Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global T Cell Antigen Gp39 Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global T Cell Antigen Gp39 Consumption by Region (2012-2017)
    4.2 North America T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)
    4.3 Europe T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)
    4.4 China T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)
    4.5 Japan T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)
    4.7 India T Cell Antigen Gp39 Production, Consumption, Export, Import (2012-2017)

5 Global T Cell Antigen Gp39 Production, Revenue (Value), Price Trend by Type
    5.1 Global T Cell Antigen Gp39 Production and Market Share by Type (2012-2017)
    5.2 Global T Cell Antigen Gp39 Revenue and Market Share by Type (2012-2017)
    5.3 Global T Cell Antigen Gp39 Price by Type (2012-2017)
    5.4 Global T Cell Antigen Gp39 Production Growth by Type (2012-2017)

6 Global T Cell Antigen Gp39 Market Analysis by Application
    6.1 Global T Cell Antigen Gp39 Consumption and Market Share by Application (2012-2017)
    6.2 Global T Cell Antigen Gp39 Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global T Cell Antigen Gp39 Manufacturers Profiles/Analysis
    7.1 Biogen, Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Biogen, Inc. T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bristol-Myers Squibb Company
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 eTheRNA Immunotherapies NV
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 ImmuNext, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 ImmuNext, Inc. T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Juno Therapeutics Inc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Juno Therapeutics Inc. T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 MedImmune, LLC
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 MedImmune, LLC T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Targovax AS
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Targovax AS T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 XL-protein GmbH
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 T Cell Antigen Gp39 Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 XL-protein GmbH T Cell Antigen Gp39 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview

8 T Cell Antigen Gp39 Manufacturing Cost Analysis
    8.1 T Cell Antigen Gp39 Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of T Cell Antigen Gp39

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 T Cell Antigen Gp39 Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of T Cell Antigen Gp39 Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global T Cell Antigen Gp39 Market Forecast (2017-2022)
    12.1 Global T Cell Antigen Gp39 Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global T Cell Antigen Gp39 Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global T Cell Antigen Gp39 Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global T Cell Antigen Gp39 Price and Trend Forecast (2017-2022)
    12.2 Global T Cell Antigen Gp39 Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India T Cell Antigen Gp39 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global T Cell Antigen Gp39 Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global T Cell Antigen Gp39 Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer


List of Tables and Figures

    Figure Picture of T Cell Antigen Gp39
    Figure Global T Cell Antigen Gp39 Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
    Figure Global T Cell Antigen Gp39 Production Market Share by Types (Product Category) in 2016
    Figure Product Picture of ECI-006
    Table Major Manufacturers of ECI-006
    Figure Product Picture of Hepatitis B vaccine
    Table Major Manufacturers of Hepatitis B vaccine
    Figure Product Picture of INX-021
    Table Major Manufacturers of INX-021
    Figure Product Picture of ISF-35
    Table Major Manufacturers of ISF-35
    Figure Product Picture of Others
    Table Major Manufacturers of Others
    Figure Global T Cell Antigen Gp39 Consumption (K Pcs) by Applications (2012-2022)
    Figure Global T Cell Antigen Gp39 Consumption Market Share by Applications in 2016
    Figure Graft Versus Host Disease Examples
    Table Key Downstream Customer in Graft Versus Host Disease
    Figure Breast Cancer Examples
    Table Key Downstream Customer in Breast Cancer
    Figure Bladder Cancer Examples
    Table Key Downstream Customer in Bladder Cancer
    Figure Panceratic Cancer Examples
    Table Key Downstream Customer in Panceratic Cancer
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global T Cell Antigen Gp39 Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
    Figure North America T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global T Cell Antigen Gp39 Revenue (Million USD) Status and Outlook (2012-2022)
    Figure Global T Cell Antigen Gp39 Capacity, Production (K Pcs) Status and Outlook (2012-2022)
    Figure Global T Cell Antigen Gp39 Major Players Product Capacity (K Pcs) (2012-2017)
    Table Global T Cell Antigen Gp39 Capacity (K Pcs) of Key Manufacturers (2012-2017)
    Table Global T Cell Antigen Gp39 Capacity Market Share of Key Manufacturers (2012-2017)
    Figure Global T Cell Antigen Gp39 Capacity (K Pcs) of Key Manufacturers in 2016
    Figure Global T Cell Antigen Gp39 Capacity (K Pcs) of Key Manufacturers in 2017
    Figure Global T Cell Antigen Gp39 Major Players Product Production (K Pcs) (2012-2017)
    Table Global T Cell Antigen Gp39 Production (K Pcs) of Key Manufacturers (2012-2017)
    Table Global T Cell Antigen Gp39 Production Share by Manufacturers (2012-2017)
    Figure 2016 T Cell Antigen Gp39 Production Share by Manufacturers
    Figure 2017 T Cell Antigen Gp39 Production Share by Manufacturers
    Figure Global T Cell Antigen Gp39 Major Players Product Revenue (Million USD) (2012-2017)
    Table Global T Cell Antigen Gp39 Revenue (Million USD) by Manufacturers (2012-2017)
    Table Global T Cell Antigen Gp39 Revenue Share by Manufacturers (2012-2017)
    Table 2016 Global T Cell Antigen Gp39 Revenue Share by Manufacturers
    Table 2017 Global T Cell Antigen Gp39 Revenue Share by Manufacturers
    Table Global Market T Cell Antigen Gp39 Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
    Figure Global Market T Cell Antigen Gp39 Average Price (USD/Pcs) of Key Manufacturers in 2016
    Table Manufacturers T Cell Antigen Gp39 Manufacturing Base Distribution and Sales Area
    Table Manufacturers T Cell Antigen Gp39 Product Category
    Figure T Cell Antigen Gp39 Market Share of Top 3 Manufacturers
    Figure T Cell Antigen Gp39 Market Share of Top 5 Manufacturers
    Table Global T Cell Antigen Gp39 Capacity (K Pcs) by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Capacity Market Share by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Capacity Market Share by Region (2012-2017)
    Figure 2016 Global T Cell Antigen Gp39 Capacity Market Share by Region
    Table Global T Cell Antigen Gp39 Production by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Production (K Pcs) by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Production Market Share by Region (2012-2017)
    Figure 2016 Global T Cell Antigen Gp39 Production Market Share by Region
    Table Global T Cell Antigen Gp39 Revenue (Million USD) by Region (2012-2017)
    Table Global T Cell Antigen Gp39 Revenue Market Share by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Revenue Market Share by Region (2012-2017)
    Table 2016 Global T Cell Antigen Gp39 Revenue Market Share by Region
    Figure Global T Cell Antigen Gp39 Capacity, Production (K Pcs) and Growth Rate (2012-2017)
    Table Global T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table North America T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table Europe T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table China T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table Japan T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table Southeast Asia T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table India T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Table Global T Cell Antigen Gp39 Consumption (K Pcs) Market by Region (2012-2017)
    Table Global T Cell Antigen Gp39 Consumption Market Share by Region (2012-2017)
    Figure Global T Cell Antigen Gp39 Consumption Market Share by Region (2012-2017)
    Figure 2016 Global T Cell Antigen Gp39 Consumption (K Pcs) Market Share by Region
    Table North America T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table Europe T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table China T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table Japan T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table Southeast Asia T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table India T Cell Antigen Gp39 Production, Consumption, Import & Export (K Pcs) (2012-2017)
    Table Global T Cell Antigen Gp39 Production (K Pcs) by Type (2012-2017)
    Table Global T Cell Antigen Gp39 Production Share by Type (2012-2017)
    Figure Production Market Share of T Cell Antigen Gp39 by Type (2012-2017)
    Figure 2016 Production Market Share of T Cell Antigen Gp39 by Type
    Table Global T Cell Antigen Gp39 Revenue (Million USD) by Type (2012-2017)
    Table Global T Cell Antigen Gp39 Revenue Share by Type (2012-2017)
    Figure Production Revenue Share of T Cell Antigen Gp39 by Type (2012-2017)
    Figure 2016 Revenue Market Share of T Cell Antigen Gp39 by Type
    Table Global T Cell Antigen Gp39 Price (USD/Pcs) by Type (2012-2017)
    Figure Global T Cell Antigen Gp39 Production Growth by Type (2012-2017)
    Table Global T Cell Antigen Gp39 Consumption (K Pcs) by Application (2012-2017)
    Table Global T Cell Antigen Gp39 Consumption Market Share by Application (2012-2017)
    Figure Global T Cell Antigen Gp39 Consumption Market Share by Applications (2012-2017)
    Figure Global T Cell Antigen Gp39 Consumption Market Share by Application in 2016
    Table Global T Cell Antigen Gp39 Consumption Growth Rate by Application (2012-2017)
    Figure Global T Cell Antigen Gp39 Consumption Growth Rate by Application (2012-2017)
    Table Biogen, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Biogen, Inc. T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Biogen, Inc. T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure Biogen, Inc. T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure Biogen, Inc. T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table eTheRNA Immunotherapies NV Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table ImmuNext, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table ImmuNext, Inc. T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure ImmuNext, Inc. T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure ImmuNext, Inc. T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure ImmuNext, Inc. T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table Juno Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Juno Therapeutics Inc. T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table MedImmune, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table MedImmune, LLC T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure MedImmune, LLC T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure MedImmune, LLC T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure MedImmune, LLC T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table Targovax AS Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Targovax AS T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Targovax AS T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure Targovax AS T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure Targovax AS T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table XL-protein GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table XL-protein GmbH T Cell Antigen Gp39 Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure XL-protein GmbH T Cell Antigen Gp39 Production Growth Rate (2012-2017)
    Figure XL-protein GmbH T Cell Antigen Gp39 Production Market Share (2012-2017)
    Figure XL-protein GmbH T Cell Antigen Gp39 Revenue Market Share (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of T Cell Antigen Gp39
    Figure Manufacturing Process Analysis of T Cell Antigen Gp39
    Figure T Cell Antigen Gp39 Industrial Chain Analysis
    Table Raw Materials Sources of T Cell Antigen Gp39 Major Manufacturers in 2016
    Table Major Buyers of T Cell Antigen Gp39
    Table Distributors/Traders List
    Figure Global T Cell Antigen Gp39 Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Global T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global T Cell Antigen Gp39 Price (Million USD) and Trend Forecast (2017-2022)
    Table Global T Cell Antigen Gp39 Production (K Pcs) Forecast by Region (2017-2022)
    Figure Global T Cell Antigen Gp39 Production Market Share Forecast by Region (2017-2022)
    Table Global T Cell Antigen Gp39 Consumption (K Pcs) Forecast by Region (2017-2022)
    Figure Global T Cell Antigen Gp39 Consumption Market Share Forecast by Region (2017-2022)
    Figure North America T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure North America T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table North America T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Figure Europe T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Europe T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Europe T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Figure China T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure China T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table China T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Figure Japan T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Japan T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Japan T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Figure Southeast Asia T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Southeast Asia T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Figure India T Cell Antigen Gp39 Production (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure India T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table India T Cell Antigen Gp39 Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
    Table Global T Cell Antigen Gp39 Production (K Pcs) Forecast by Type (2017-2022)
    Figure Global T Cell Antigen Gp39 Production (K Pcs) Forecast by Type (2017-2022)
    Table Global T Cell Antigen Gp39 Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Global T Cell Antigen Gp39 Revenue Market Share Forecast by Type (2017-2022)
    Table Global T Cell Antigen Gp39 Price Forecast by Type (2017-2022)
    Table Global T Cell Antigen Gp39 Consumption (K Pcs) Forecast by Application (2017-2022)
    Figure Global T Cell Antigen Gp39 Consumption (K Pcs) Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Source



Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...